DV

Dileep Valomattathil Raveendran

Active Director Director DIN 09785900
DIN 09785900 First appointment Nov 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Dileep Valomattathil Raveendran

Data last updated:

Dileep Valomattathil Raveendran is a Director at Avacus Pharmaceuticals Private Limited (since 2022). The company operates in Trading.

DIN 09785900
Primary Designation Director
Industry Trading
First Appointment 10 Nov 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20222022Active

Board colleagues of Dileep Valomattathil Raveendran

Directorship timeline

Open interactive timeline →
Avacus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dileep Valomattathil Raveendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dileep Valomattathil Raveendran

Dileep Valomattathil Raveendran currently holds 1 directorship: Avacus Pharmaceuticals Private Limited (Director, since 10 Nov 2022).

Dileep Valomattathil Raveendran was first appointed on 10 Nov 2022 as Director at Avacus Pharmaceuticals Private Limited.

The current boards of Dileep Valomattathil Raveendran's companies include Chandrasekharan Nair Rajagopal (Avacus Pharmaceuticals Private Limited), Larsan Joy (Avacus Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available